Search

everythinglearnresearchcommunity

for

Search:↓

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

TGM3 is important for skin and hair structure and may help diagnose cancer.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Experts discussed hair care, genetic hair defects, hair loss treatments, nail surgery, lupus treatments, skin infections, and cosmetic allergies.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Type I interferons play a key role in the development of various skin diseases.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

A new staining method shows a special area in the hair's skin layer with lots of proteoglycans.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

The conclusion is that analyzing RNA from skin oils is a promising way to understand skin diseases.

The document concludes that improving patient safety and quality is increasingly important in dermatology.

The document discusses hair and nail conditions, updates on treatments for alopecia, and controversies around finasteride use.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document explains various skin conditions and their treatments.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Kidney transplant patients often have skin issues, mainly infections.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Doctors need to understand statistics to properly evaluate clinical trials for patient care.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

The document suggests a bacteria plays a significant role in acne rosacea and that white hair can regain color after transplant, meriting more research on reversing grey hair.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.